Charles River Laboratories Announces Second-Quarter 2026 Results
Revenue$1.00 billion−2.7% YoY
Adj. EPS$3.02−3.2% YoY
Outlookrevisedguidance
Company · CRL
Earnings coverage
Delayed up to 15 min · Source: Finnhub · Not investment advice
Widgets by TradingView. They load only when you click, so the page stays fast.
Forensic equity research on US stocks. No spam, unsubscribe anytime.